⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Stella PopovaM.D.

Internal Medicine · Los Angeles, CA 90046

NPI: 1023108925

Share:

24

🟡 Moderate

Risk Flags

Elevated cost per beneficiaryElevated antipsychotic prescribing (65+)Opioid + benzodiazepine co-prescriberExtreme fills per patient

Risk indicators are statistical patterns, not allegations. Learn more

12,439

Total Claims

$1.9M

Drug Cost

223

Beneficiaries

$8,327

Cost/Patient

Risk Score Breakdown 24/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid + benzodiazepine combo+8
Elderly antipsychotic prescribing+5
High fills per patient+5
Cost per patient outlier+3

Score components are additive. Read full methodology

Peer Comparison vs. 110,156 Internal Medicine providers

-23%

Opioid rate vs peers

1.7% vs 2.2% avg

+490%

Cost per patient vs peers

$8,327 vs $1,411 avg

+77%

Brand preference vs peers

18.8% vs 10.6% avg

⚠️ Opioid + Benzodiazepine Co-Prescriber

This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.

🔎 Data Overview

⚠️

This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Opioid Prescribing

1.7%

Opioid Rate

214

Opioid Claims

$2,162

Opioid Cost

Long-Acting Rate

Brand vs Generic

81% generic

Brand: 2,332 claims · $1.0M

Generic: 10,061 claims · $838K

Top Prescribed Drugs

Drug (Generic)ClaimsCost
Omeprazole/Sodium Bicarbonate154$345K
Metformin Hcl49$124K
Linagliptin171$99K
Diclofenac Sodium306$98K
Lipase/Protease/Amylase170$95K
Empagliflozin145$93K
Linaclotide155$87K
Dexlansoprazole239$57K
Sitagliptin Phos/Metformin Hcl100$53K
Mirabegron98$48K
Dulaglutide46$48K
Icosapent Ethyl154$47K
Semaglutide41$44K
Apixaban56$35K
Lidocaine163$35K

Prescribing Profile

164

Unique Drugs

$161K

IRA Negotiated Drugs

$107K

GLP-1 Drugs

24.0

Anomaly Score

Patient Profile

80

Avg Age

67%

Female

1.67

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data